Resection for Pancreatic Cancer Lung Metastases.
10.5090/kjtcs.2017.50.5.326
- Author:
Masayuki OKUI
1
;
Takashi YAMAMICHI
;
Ayaka ASAKAWA
;
Masahiko HARADA
;
Hirotoshi HORIO
Author Information
1. Department of Thoracic Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Korea. mokui@cick.jp
- Publication Type:Original Article
- Keywords:
Lung;
Metastasis;
Pancreatic neoplasms
- MeSH:
Adenocarcinoma;
Follow-Up Studies;
Humans;
Lung*;
Neoplasm Metastasis*;
Pancreatectomy;
Pancreatic Neoplasms*;
Retrospective Studies;
Survival Rate
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2017;50(5):326-328
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: Pancreatic cancer is a highly aggressive solid tumor. Patients with metastases from pancreatic cancer have poor survival rates. Here, we report the outcomes of 6 patients for whom resection of lung metastases was performed after a pancreatectomy to treat pancreatic cancer. METHODS: We retrospectively reviewed the perioperative clinical data of patients with lung metastases resulting from primary pancreatic cancer who were treated with lung resection between 2008 and 2015. We report 6 cases where lung resection was performed to treat lung metastases after a pancreatectomy. RESULTS: The number of lung metastases was 1 in 5 cases and 2 in 1 case. The surgical procedures performed to treat the lung metastases included 4 wedge resections and 2 lobectomies. The cell type of the primary tumor and metastases was tubular adenocarcinoma in 5 cases and intraductal papillary-mucinous carcinoma in 1 case. All 6 patients survived with a mean follow-up period of 65.6 months, although the disease recurred in 2 patients. CONCLUSION: Resection of lung metastases resulting from primary pancreatic cancer may lengthen survival, provided the patient can tolerate surgery.
